Close Menu

NEW YORK (GenomeWeb) – Sysmex, a Japanese in vitro diagnostics company, has signed a deal to acquire all the shares of Oxford Gene Technology, OGT said today.

Upon completion of the deal, OGT will become a wholly owned subsidiary of Sysmex. Further terms were not disclosed, though OGT CFO Tim Hall said that the deal is likely to close by mid-June.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.